Candel Therapeutics Inc (CADL)

SG&A Expenses

$22.86M

TTM · Period ending: · USD

CADL logo

CADL SG&A Expenses

Latest reported$22.86M
CADL TTM SG&A Expenses ($5.98M → $22.86M)
High-resolution chart · PNG

CADL sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Candel Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
22,859,000
20,100,000
17,770,000
16,370,000
14,965,000
14,371,000
14,057,000
13,793,000
13,468,000
13,521,000
13,885,000
13,985,000
14,505,000
14,622,000
14,058,000
14,815,000
14,074,000
12,352,000
10,687,000
10,204,000
8,376,000
7,191,000
5,984,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.